• STOK

Stoke Therapeutics' drug 'zorevunersen' earns FDA breakthrough tag; shares leap

Stoke Therapeutics' zorevunersen receives Breakthrough Therapy Designation from the FDA for Dravet syndrome, aiming for market approval after positive clinical trial outcomes.